These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30032128)

  • 1. The clinical significance of borderline results of the Elia CTD Screen assay.
    Robier C; Amouzadeh-Ghadikolai O
    Clin Chem Lab Med; 2018 Nov; 56(12):2088-2092. PubMed ID: 30032128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical relevance of anti-dsDNA antibodies determined by the Elia™ dsDNA assay in patients with negative indirect immunofluorescence on the HEp-2 cell.
    Robier C; Haas M; Quehenberger F
    Clin Chem Lab Med; 2021 Feb; 59(3):541-546. PubMed ID: 33064668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the clinical utility of the Elia CTD Screen to indirect immunofluorescence on Hep-2 cells.
    Robier C; Amouzadeh-Ghadikolai O; Stettin M; Reicht G
    Clin Chem Lab Med; 2016 Aug; 54(8):1365-70. PubMed ID: 26677892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low positive rate of serum autoantibodies in colorectal cancer patients without systemic rheumatic diseases.
    Fernández-Suárez A; Muñoz-Colmenero A; Ocaña-Pérez E; Fatela-Cantillo D; Domínguez-Jiménez JL; Díaz-Iglesias JM
    Autoimmunity; 2016 Sep; 49(6):383-387. PubMed ID: 27424781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
    Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
    Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for connective tissue disease-associated antibodies by automated immunoassay.
    Willems P; De Langhe E; Claessens J; Westhovens R; Van Hoeyveld E; Poesen K; Vanderschueren S; Blockmans D; Bossuyt X
    Clin Chem Lab Med; 2018 May; 56(6):909-918. PubMed ID: 29306915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
    González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
    Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of anti-DFS70 autoantibodies.
    Kang SY; Lee WI; Kim MH; La Jeon Y
    Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an Automated Screening Assay, Compared to Indirect Immunofluorescence, an Extractable Nuclear Antigen Assay, and a Line Immunoassay in a Large Cohort of Asian Patients with Antinuclear Antibody-Associated Rheumatoid Diseases: A Multicenter Retrospective Study.
    Jeong S; Hwang H; Roh J; Shim JE; Kim J; Kim GT; Tag HS; Kim HS
    J Immunol Res; 2018; 2018():9094217. PubMed ID: 29854849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
    Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
    Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients].
    Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H
    Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening.
    González Rodríguez C; Fuentes Cantero S; Pérez Pérez A; Vázquez Barbero FJ; León Justel A
    J Clin Lab Anal; 2021 Sep; 35(9):e23914. PubMed ID: 34347308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of anti-nuclear antibodies from filter paper blood clots using indirect immunoenzyme technique: preliminary experience and results.
    Chopra A; Anuradha V; Edmonds J
    J Assoc Physicians India; 2000 May; 48(5):493-6. PubMed ID: 11273141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
    Broadfoot A; Sivertsen T; Baumgart K
    Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinuclear antibody titration and pattern are helpful in the diagnosis of systemic autoimmune rheumatic diseases.
    Mohd Razi MS; Sugumaran Y; Mohd Haniz NA; Khilmie K; Osmera AH; Jauhary EJ; Wahab AA
    Malays J Pathol; 2024 Apr; 46(1):63-69. PubMed ID: 38682845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Performance and clinical evaluation of antinuclear antibody test based on fluorescence enzyme immunoassay].
    Watanabe N; Nagatomo R; Okubo S; Yokota H; Ikeda H; Yatomi Y
    Rinsho Byori; 2014 Apr; 62(4):315-23. PubMed ID: 25022060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
    Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
    Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of Indirect immunofluorescence (IIF) alone as a screening method for antinuclear antibody in connective diseases in India's sub-Himalayan region.
    Kalita D; Rekha US; Raj AK; Mahanta P; Gupta P; Deka S
    Indian J Pathol Microbiol; 2022; 65(4):873-878. PubMed ID: 36308197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of antinuclear antibodies and their fine specificities: time for a change in strategy?
    Otten HG; Brummelhuis WJ; Fritsch-Stork R; Leavis HL; Wisse BW; van Laar JM; Derksen RHWM
    Clin Exp Rheumatol; 2017; 35(3):462-470. PubMed ID: 28240588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
    Vos PA; Bast EJ; Derksen RH
    Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.